First heart patch transplant moves iPS therapy from lab to clinic

OSAKA—A regenerative medical product derived from induced pluripotent stem (iPS) cells was used to treat a patient in a clinical setting here for the first time in the world.

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.asahi.com)